Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis

Kidney International

Volumn 57, Issue 2, 2000, Pages 518-525

  Kitching, A Richard ^a,b   Tipping, Peter G ^a   Timoshanko, Jennifer R ^a   Holdsworth, Stephen R ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Cytokines; Delayed type hypersensitivity; Fibrin; Macrophage; Nephritogenic Th1 response; T cell

Indexed keywords

INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CYTOKINE PRODUCTION; FEMALE; FIBRIN DEPOSITION; GLOMERULONEPHRITIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL;

EID: 0033934436     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00872.x     Document Type: Article

References (33)

1. 1. MOSMANN TR: Properties and functions of interleukin-10. Adv Immunol 56:1-26, 1994
2. 2. FOUQUERAY B, BOUTARD V, PHILIPPE C, KORNREICH A, MARCHANT A, PEREZ J, GOLDMAN M, BAUD L: Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide. Am J Pathol 147:176-182, 1995
3. 3. DE WAAL MALEFYT R, HAANEN J, SPITS H, RONCAROLO MG, TE VELDE A, FIGDOR C, JOHNSON K, KASTELEIN R, YSSEL H, DE VRIES JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med 174:915-924, 1991
4. 4. KOCH F, SIANZL U, JENNEWEIN P, JANKE K, HEUFLER C, KAMPGEN E, ROMANI N, SCHULER G: High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 184:741-746, 1996
5. 5. BUELENS C, WILLEMS F, DELVAUX A, PIERARD G, DELVILLE JP, VELU T, GOLDMAN M: Interleukin-10 differentially regulates B7-1 (CD80) and B72 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 25:2668-2672, 1995
6. 6. BOGDAN C, NATHAN C: Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann NY Acad Sci 685:713-739, 1993
7. 7. PRADIER O, GERARD C, DELVAUX A, LYBIN M, ABRAMOWICZ D, CAPEL P, VELU T, GOLDMAN M: Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 23:2700-2703, 1993
8. 8. FIORENTINO DF, ZLOTNIK A, MOSMANN TR, HOWARD M, O'GARRA A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822, 1991
9. 9. WU J, CUNHA FQ, LIEW FY, WEISER WY: IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation. J Immunol 151:4325-4332, 1993
10. 10. TE VELDE AA, DE WAAL MALEFYT R, HUIJBENS RJ, DE VRIES JE, FIGDOR CG: IL-10 stimulates monocyte FcγR surface expression and cytotoxic activity: Distinct regulation of antibody-dependent cellular cytotoxicity By IFN-γ, IL-4, and IL-10. J Immunol 149:4048-4052, 1992
11. 11. MARCHANT A, BRUYNS C, VANDENABEELE P, DUCARME M, GERARD C, DELVAUX A, DE GROOTE D, ABRAMOWICZ D, VELU T, GOLDMAN M: Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 24:1167-1171, 1994
12. 12. BERG DJ, LEACH MW, KUHN R, RAJEWSKY K, MULLER W, DAVIDSON NJ, RENNICK D: Interleukin 10 hut not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182:99-108, 1995
13. 13. SEGAL BM, DWYER BK, SHEVACH EM: An interleukin (IL)-10/ IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 187:537-546, 1998
14. 14. RAISANEN-SOKOLOWSKI A, MOTTRAM PL, GLYSING-JENSEN T, SATOSKAR A, RUSSELL ME: Heart transplants in interferon-γ, interleukin 4, and interleukin 10 knockout mice: Recipient environment alters graft rejection. J Clin Invest 100:2449-2456, 1997
15. 15. NIEMIR ZI, ONDRACEK M, DWORACKI G, STEIN H, WALDHERR R, RITZ E, OTTO HF: In situ upregulation of IL-10 reflects the activity of human glomerulonephritides. Am J Kidney Dis 32:80-92, 1998
16. 16. CHADBAN SJ, NIKOLIC-PATERSON DJ: Interleukin-10: Is it good or bad for the kidney? Nephrology 4:331-338, 1998
17. 17. LAKKIS FG, BADDOURA FK, CRUET EN, PAREKH KR, FUKUNAGA M, MUNGER KA: Anti-inflammatory lymphokine mRNA expression in antibody-induced glomerulonephritis. Kidney Int 49:117-126, 1996
18. 18. KUHN R, LOHLER J, RENNICK D, RAJEWSKY K, MULLER W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274, 1993
19. 19. KITCHING AR, HOLDSWORTH SR, TIPPING PG: IFN-γ mediates crescent formation and cell mediated immunity in murine glomerulonephritis. J Am Soc Nephrol 10:752-759, 1999
20. 20. HUANG XR, TIPPING PG, LI S, HOLDSWORTH SR: Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis. Kidney Int 51:94-103, 1997
21. 21. KITCHING AR, HOLDSWORTH SR, CARMELIET P, COLLEN D, PLOPLIS VA, PLOW EF, TIPPING PG: Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 185:963-968, 1997
22. 22. TIPPING PG, KITCHING AR, HUANG XR, MUTCH DA, HOLDSWORTH SR: Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 27:530-537, 1997
23. 23. DOWNING LJ, STRIETER RM, KADELL AM, WILKE CA, AUSTIN JC, HARE BD, BURDICK MD, GREENFIELD LJ, WAKEFIELD TW: IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol 161:1471-1476, 1998
24. 24. KATSIKIS PD, CHU CQ, BRENNAN FM, MAINI RN, FELDMANN M: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179:1517-1527, 1994
25. 25. KENNEDY MK, TORRANCE DS, PICHA KS, MOHLER KM: Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 149:2496-2505, 1992
26. 26. KITCHING AR, TIPPING PG, MUTCH D, HUANG XR, HOLDSWORTH SR: Interleukin 4 deficiency enhances Th1 responses and promotes crescentic glomerulonephritis in mice. Kidney Int 53:112-118, 1998
27. 27. KITCHING AR, TIPPING PG, HOLDSWORTH SR: Interleukin-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur J Immunol 29:1-10, 1999
28. 28. CHADBAN SJ, TESCH GH, FOTI R, ATKINS RC, NIKOLIC-PATERSON DJ: Interleukin-10 is a mesangial cell growth factor in vitro and in vivo. Lab Invest 76:619-627, 1997
29. 29. DAI Z, LI X, WANG H: Inhibitory effect of interleukin-10 on inflammatory reaction in rat mesangial cells [Chinese]. Chin Med J 76:407-410, 1996
30. 30. CHADBAN SJ, TESCH GH, FOTI R, LAN HY, ATKINS RC, NIKOLIC-PATERSON DJ: Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo. Immunology 94:72-78, 1998
31. 31. KITCHING AR, TIPPING PG, HUANG XR, MUTCH D, HOLDSWORTH SR: Interleukin-4 and interleukin-10 attenuates established crescentic glomerulonephritis in mice. Kidney Int 52:52-59, 1997
32. 32. HUANG XR, KITCHING AR, TIPPING PG, HOLDSWOTH SR: Interleukin-10 inhibits macrophage induced glomerular injury. J Am Soc Nephrol (in press)
33. 33. ISHIDA H, MUCHAMUEL T, SAKAGUCHI S, ANDRADE S, MENON S, HOWARD M: Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305-310, 1994